US Stock Market Move | New drug Kaitongle has been approved for market in China, and ZAI LAB (ZLAB.US) rose more than 7%.
As of the time of drafting, the stock rose more than 7%, reaching $18.84 per share.
On Wednesday, the stock price of Zai Lab (ZLAB.US) rose, as of the time of writing, the stock rose more than 7%, to $18.84. The stock of Zai Lab in Hong Kong rose 6.24% today. In terms of news, Zai Lab announced that the China National Medical Products Administration has approved the new drug application for Pimozide Quetiapine Capsules (Kaitielle), used to treat adult schizophrenia. This is the first schizophrenia therapy with a completely new mechanism of action to be approved in over 70 years, marking a breakthrough in the treatment of schizophrenia.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
